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Abstract
Background: Discussion has been continued concerning Calorie Restriction (CR) and Low Carbohydrate Diet
(LCD). For years, authors have investigated LCD associated with lipids, renal function and Ketone Bodies (KB) for
clinical application of super LCD formular meal. In this study, 3-hydroxybutyric acid (3-OHBA) and acetoacetic acid
(AcAc) was measured.
Subjects and Methods: The subjects were 105 patients with type 2 diabetes mellitus (T2DM), (M/F 47/58, 62.7
years. in average) they were admitted for treatment of T2DM. The protocol consists of 3 steps. 1. Calorie Restriction
(CR) diet was given on day 1 and 2 with 60% of carbohydrates. 2. Low Carbohydrate Diet (LCD) was given after day
3 with 12% of carbohydrates which is super-LCD formula meal. 3. Total ketone bodies (T-KB), 3-OHBA and AcAc
were measured, and investigated the value and ratio of these markers.
Results: Median T-KB was 349, 415, 486, 415, 445 μmol/L, in day 4-6, 7-9, 10-11, 12-15, 21-30, in 5 groups,
respectively. There was significant correlation between value of 3-OHBA and ratio of 3-OHBA / T-KB (p<0.01,
r=0.72). When 3-OHBA value was less or more than 1000 μmol/L, 3-OHBA ratio showed 65-89% or 90-94%,
respectively.
Discussion and Conclusion: Hyperketonemia is due to continuation of LCD, which is physiological ketosis
without clinically hazardous acidosis. As value of 3-OHBA increased, the ratio of 3-OHBA/T-KB increased. These
results may become the fundamental data for clarifying the pathophysiological role of 3-OHBA and AcAc in
hyperketonemia from carbohydrate restriction.
Keywords: Low carbohydrate diet; Type 2 diabetes mellitus; Ketone
bodies; 3-hydroxybutyric acid; β-hydroxybutyrate; Acetoacetic acid
Introduction
For years, lots of discussion has been found concerning Calorie
Restriction (CR) and Low Carbohydrate Diet (LCD). Atkins and
Bernstein have originally begun LCD, which had been an new idea at
that time [1,2]. After that, the efficacy of LCD has been known and
reported in Western countries [3-6].
On contrast in Japan, the author and colleague researchers have
firstly started LCD and continued clinical research [7,8]. Furthermore,
we clarified the physiological important role of ketone bodies in the
axis of fetus, placenta, newborn and mother, and associated changes of
renal and lipid aspects [9-12]. Through our clinical research about
LCD and ketone bodies, we have accumulated lots of experiences of
treatment for type 2 diabetes mellitus (T2DM) by super LCD
therapeutic meal [13,14].
In recent years, clinical significance of hyperketonemia has been in
focus, because of the possibilities for various beneficial functions
[15-17]. Previous data from compared results of animal species and
biochemical results revealed that fetuses would be grown by using
ketogenic energy throughout evolution [18]. 3-hydroxybutyric acid (β-
hydrxybutyrte, 3-OHBA) seemed to be the energy source or basic
engine that produces energy in all terrestrial species [19].
Combined these situations together, we investigated the values of
total Ketone Bodies (KB), 3-OHBA and acetoacetic acid (AcAc) in the
patients with T2DM during nutritional treatment of super LCD.
Subjects and Methods
The subjects enrolled in this study were 105 patients with T2DM
(M/F 47/58, 62.7 ± 10.2 years old in average). Methods were
summarized as follows. They were admitted for further evaluation and
treatment of T2DM. The protocol of research has 3 steps with 1, 2 and
3.
1. CR diet was given on day 1 and 2, which had 60% carbohydrates,
25% lipids and 15% protein with 1400 kcal/day. As for CR, the content
is along the guideline of Japan Diabetes Society, in which PFC ratio is
14.7%, 26.9%, 58.4%, respectively [20]. This ratio has been stable from
1985 to 2015 on the national survey in Japan [21].
2. LCD was given and continued after day 3, which had 12%
carbohydrates, 64% lipids and 24% protein with 1400 kcal/day. This
LCD has been so-called “super-LCD formula” in our clinical research
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for LCD. It is one of the Very low-carbohydrate ketogenic diet
(VLCKD) by the definitions of LCD, and was originated by Dr. Ebe
who is one of the author in Japan [13,14].
3. We measured lots of biomarkers of glucose, lipids and renal
function, as well as KB. According to the date that total ketone body
(T-KB) was measured, subjects were classified into 5 groups (Table 1).
From those data obtained above, complete data including 3
components that are T-KB, 3-OHBA and AcAc were 66 samples. We
investigated the correlation among these components (Table 2).
Variables Group-1 Group-2 Group-3 Group-4 Group-5
Classification days on LCD 4-6 7-9 10-11 12-15 21-30
Subjects
Number 17 23 25 19 21
M/F 9/8 13/10 11/14 5/14 9/12
Age average 64.1 63 61.8 62.1 62.6
SD 9.3 10.9 9.9 10.1 10.4
Total ketone body median μmol/L 349 415 486 415 445
Table 1: T-KB values on LCD due to LCD duration.
Variables Age (YO) T-KB (μmol/L) 3-OHBA (μmol/L) AcAc (μmol/L) 3-OHBA (%) AcAc (%)
Average 60.7 662 115 21.3 78.5 21.5
SD 9.3 650 72 6.9 7.2 6.9
Median 63.0 460 98 21.8 78.2 21.8
Quartile 25% 55.0 320 77 17.3 75.0 17.3
Quartile 75% 66.8 754 129 24.7 82.7 24.7
Minimum 34.0 99 63 31.0 62.4 5.5
Maximum 78.0 4000 3577 42.3 94.5 37.6
T-KB: Total ketone bodies; 3-OHBA: 3-hydroxybutyric acid; AcAc: Acetoacetic acid; SD-Standard deviation; YO-Years old
Table 2: Correlation among T-KB, 3-OHBA and AcAc.
Statistical analyses
In this study, obtained data was represented as the mean ± standard
deviation (SD) and also represented median, quartile of 25% and 75%
in biomarkers. For statistical analyses, correlation coefficients were
calculated using Pearson or Spearman test of the Microsoft excel
analytical tool, which is four steps excel statistics 4th edition [22].
Intergroup comparisons were made using the Wilcoxon rank sum
test or the Bonferroni multiple comparisons (Lambert method). A
significance level of less than 5% obtained using a two-tailed test was
considered to be statistically significant.
Ethical Considerations
Current study was conducted in compliance with the ethical
principles of the declaration of Helsinki and Japan’s act on the
Protection of Personal Information along with the Ministerial
Ordinance on Good Clinical Practice (GCP) for drug (Ordinance of
Ministry of Health and Welfare No. 28 of March 27, 1997). No ethical
committee meeting was held. Informed consent was obtained from the
subjects. The study was registered with UMIN #R000031211.
Results
T-KB values during LCD:
The basal data of 105 patients enrolled were shown in Table 1.
Median value of T-KB in 5 groups was 349, 415, 486, 415 and 445
μmol/L, respectively. T-KB values representing by boxplot were shown
in (Figure 1).
Ratio of 3-OHBA/T-KB:
The results concerning the ratio among T-KB, 3-OHBA and AcAc
were shown in Table 2. There was significant correlation between value
of 3-OHBA and ratio of 3-OHBA/T-KB (p<0.01) (Figure 2). When 3-
OHBA value is around less than 1000 μmol/L, 3-OHBA ratio ranges
from 65% and 89%. When 3-OHBA value is more than 1000 μmol/L,
3-OHBA ratio is approximately 90-94%.
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Figure 1: Total ketone bodies in 5 groups.
Figure 2: Correlation between 3-OHBA value and 3-OHBA ratio in
T-KB.
Discussion
Authors have reported clinical remarkable improvement of
hyperglycemia in this protocol using super LCD nutrition treatment so
far [8,10,11]. From recent data classified 4 groups due to HbA1c (6,6,
7,4, 8,5, 9.5%)(n=93)[11], fasting glucose on day 2 and 14 were, 117 vs.
99 mg/dL, 147 vs. 110 mg/dL, 184 vs. 119 mg/dL, 227vs. 133 mg/dL,
respectively. We have reported remarkable effect of super-LCD in short
period.
In this study, we investigated and focused ketone bodies, which are
T-KB, 3-OHBA and AcAc. On fasting situation, the metabolism of
glycolysis is decreased, in which substrates flowing into the citric acid
cycle is decreased and ketone production is started. Formerly, glucose
metabolism of fasting people was studied for forty days [23,24]. As a
result, 3-OHBA in starvation and AcAc are produced in the liver from
long-chain fatty acids, suggesting 3-OHBA as the energy source in the
brain and other tissues.
The reason of this would be the changed pathway. During the
starvation, decreased insulin levels would easily make acyl-CoA enter
the mitochondria, resulting much acetyl-CoA that is diverted into the
synthesis of ketone bodies [25]. As to ketogenic pathway,
mitochondrial 3-OH-3-methyglutaryl-CoA synthase and HMGCS2
are involved as rate limiting enzyme [26,27].
3-OHBA, AcAc and glucose seem to be used for energy sources for
the brain of the people who has elevated ketone bodies without any
symptoms for ketoacidosis [28].
The organs and tissue producing 3-OHBA seems to be liver, kidney
and brain astrocytes [29]. On fasting or severe carbohydrate
restriction, hepatocytes, renal tubular cells, intestinal epithelial cells
and astrocytes can make ketogenesis. Probable ratio in 3 organs would
be 40-60% in liver, 40% in kidney and up to 20% in astrocytes, in order
to support to maintain brain function [29]. When certain amount of
glucose is given by gluconeogenesis in liver and kidney, production of
ketone bodies decreases.
As for the beneficial role of 3-OHBA, it seems to act as a ligand to
the G-protein coupled receptor GPR109, leading to anti-inflammatory
properties [30]. It would give positive effect for health by anti-
inflammatory and anti-oxidant pathways protecting against brain
impairment, myocardial problems and arteriosclerosis [30].
In the light of clinical situation, hyperketonemia has been usually
classified into in 1) diabetic ketoacidosis (DKA) and 2) physiological
ketosis. The former revealed that blood sugar is more than 300 mg/dL
with acidosis, and ketone body is about 20-25 mmol/L [31,32]. In
clinical report for DKA, average value were: Glucose 650 mg/dL, pH
7.13, T-KB 10.2 ± 1.8 mmol/L, Acetoacetic acid (AcAc) 2.7 ± 0.5
mmol/L, 3-OHBA 7.5 ± 1.3 mmol/L the ratio of 3-OHBA 74% [33].
On contrast, the latter revealed that blood glucose is normal and
plasma ketone bodies would increase to 6-8 mM during a prolonged
fast without clinically risky acidosis [33]. The cause would be from
prolonged starvation and ketogenic diet, which was proposed by
biochemist Crebs given Nobel Prize [34].
In current study, we applied super-LCD including 1400 kcal/day,
12% of carbohydrate and 42 gm of carbohydrate per day. T-KB value
was up to 4000 μmol/L (4 mmol/L), and 3-OHBA value was up to 3.6
mmol/L. These data would be similar to previous reports.
Fasting starts to increase blood T-KB and 3-OHBA about 0.3～0.5
mmol/L in 24 hours, 1～2 mmol/L in 2-3 days, 3 mmol/L in 3-4 days
and 4-5 mmol/L in 7-10 days [24]. In previous experiment, obese
subjects continued fasting 40 days, in which they showed no acidosis
and 3-OHBA were 6-8 mmol/L [35].
The value of 3-OHBA for carbohydrate restriction until 4 weeks
seems to be compatible for previous reports, in which 0.36 mmol/L in
fasting [24]. The ratio of 3-OHBA to T-KB was reported to be about
78% [24]. In our data, the ratio of 3-OHBA was increased as the value
of 3-OHBA increased. This result may become the fundamental data
for clarifying the pathophysiological role of 3-OHBA and AcAc in
hyperketonemia due to carbohydrate restriction. Recently, the
beneficial aspect of hyper ketosis and wellness has been focused and
emphasized [36]. Consequently, further investigation among KB, LCD
and glucose metabolism would be expected to develop from now on.
Conclusion
In this study, we investigated the value and ratio of 3-OHBA and
AcAc in patients with T2DM on super LCD for nutritional treatment.
Elevated value and ratio of 3-OHBA were observed, which may
become the fundamental data for evaluation of pathophysiological role
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of 3-OHBA in the future research concerning KB, LCD and glucose
metabolism.
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